Biomarker Discovery in Lung Cancer - Malaysia

Recruiting now

Conditions studied: Lung Cancer

In brief

This study aims to 1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. 2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.

Key facts

Study ID

NCT06504927

Run by

University of Malaya

People needed

400

Starts

2024-01-16

Expected to finish

2026-12-31

Last updated by the study team

2024-07-18

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female subjects aged 30 and above.
• No previous history of any cancers.
• Able to provide X-ray and/or LDCT results.
• Have either COPD or pulmonary nodules measuring less than 11mm, or deemed not for biopsy by attending physician
• Willing to go back for a follow-up X-ray or LDCT scan in the next clinical follow up as per standard of care.
• Willing to provide up to 30mL of blood in month-0 (first visit) and up to 21mL in the next standard of care follow up visit (second visit).

You may not qualify if…

• Subject has received chemotherapy or radiotherapy for cancer treatment, and any other cancer-related treatment.
• Subject is pregnant or lactating (self-declaration).
• Subject is unwilling or unable to provide signed informed consent

Where it is running

• University of Malaya Medical Centre — Kuala Lumpur, Malaysia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.